Candriam Equities L Biotechnology Class I Fonds
1.554,45
CHF
-13,14
CHF
-0,84
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Regeneron Pharmaceuticals Inc | US75886F1075 | 6,42% |
| Amgen Inc | US0311621009 | 5,97% |
| Gilead Sciences Inc | US3755581036 | 5,17% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 5,03% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 4,82% |
| BioNTech SE ADR | US09075V1026 | 3,34% |
| Eli Lilly and Co | US5324571083 | 2,69% |
| Ascendis Pharma AS ADR | US04351P1012 | 2,27% |
| argenx SE | NL0010832176 | 2,16% |
| Biogen Inc | US09062X1037 | 2,16% |
| Sonstige | 59,96% |